Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | CCL5 |
| Upstream (Parents) |
|---|
| (<<) LYZ → CCL5 |
| (<<) CD3D → CCL5 |
| (<<) TRBC1 → CCL5 |
| Downstream (Children) |
|---|
| CCL5 → DUSP2 (>>) |
| CCL5 → CXCL13 (>>) |
| CCL5 → TRBC1///TRBC2 (>>) |
| CCL5 → TARP (>>) |
| CCL5 → XCL2///XCL1 (>>) |
| CCL5 → GBP1 (>>) |
| CCL5 → LIMD2 (>>) |
| CCL5 → PLA2G7 (>>) |
| CCL5 → EVI2B (>>) |
| CCL5 → LGALS2 (>>) |
| CCL5 → PTPRCAP (>>) |
| CCL5 → GZMH (>>) |
| CCL5 → SP140 (>>) |
| CCL5 → ARL4D (>>) |
| CCL5 → CD97 (>>) |
| CCL5 → CCR5 (>>) |
| CCL5 → CSTA (>>) |
| CCL5 → CCL8 (>>) |
| CCL5 → MBP (>>) |
| CCL5 → CST7 (>>) |
